Massimo Federici

机构：University of Rome Tor Vergata, Istituto Neurologico Mediterraneo, Policlinico Tor Vergata · ORCID：0000-0003-4989-5194

发表论文 403 篇 · 总被引 29937 次 · h-index 76

代表论文

Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control (2025 · Nature Metabolism · 被引 14)
Glycometabolic cardiac dysfunction in HFpEF: Lessons from multi-omics studies (2025 · Pharmacological Research · 被引 9)
Novel myo -inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health (2026 · Gut · 被引 6)
Dysregulation of the Gut-Adipose Tissue-Liver Axis: a Possible Mechanism Behind the Relationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes (2026 · Current Diabetes Reports · 被引 4)
Impact of semaglutide on limb events: a meta-analysis of randomized controlled trials (2026 · European Journal of Preventive Cardiology · 被引 3)
Lipid management in type 2 diabetes and non-HDL-cholesterol: target all atherogenic lipoproteins (2026 · Cardiovascular Diabetology · 被引 2)